Gestalt Diagnostics Secures $7.5M Series A to Advance AI-Driven Digital Pathology Platform

Gestalt Diagnostics is transforming pathology by integrating artificial intelligence with digital diagnostics.

Gestalt Diagnostics Secures $7.5M Series A to Advance AI-Driven Digital Pathology Platform
Source: Gestalt Diagnostics

Company Name: Gestalt Diagnostics
Location: Spokane, WA
Industry: Health Tech

Funding Details:

  • Amount: $7.5M (Series A)
  • Investors:
    • Lead: Cowles Ventures
    • Participants: TVF Funds, Inland Imaging Investments, KickStart Funds, and Pacific Northwest angel investors

Purpose of Investment:

  • Expand customer base
  • Enhance AI capabilities
  • Pursue FDA clearance

Leadership:

  • CEO: Dan Roark

Product:
Gestalt Diagnostics offers PathFlow, an AI-powered digital pathology platform that delivers faster, more accurate disease diagnosis. The platform enhances workflow efficiency, diagnostic accuracy, and supports:

  • Biomarker scoring to match patients with optimized therapies
  • Image and data analysis to study disease progression
  • Interoperability tools that streamline workflows, surface key insights, and reduce diagnostic errors

About Company:
Gestalt Diagnostics is transforming pathology by integrating artificial intelligence with digital diagnostics. Used by hospitals, academic medical centers, and research organizations, the company is enabling a future of faster, smarter, and more precise diagnoses.

Read next